These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8679688)
1. Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2. Emadi S; Elalamy I; Vargaftig BB; Hatmi M Biochim Biophys Acta; 1996 May; 1300(3):226-32. PubMed ID: 8679688 [TBL] [Abstract][Full Text] [Related]
2. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation. Faili A; Emadi S; Vargaftig BB; Hatmi M Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237 [TBL] [Abstract][Full Text] [Related]
3. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770 [TBL] [Abstract][Full Text] [Related]
4. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation. Mounier C; Faili A; Vargaftig BB; Bon C; Hatmi M Eur J Biochem; 1993 Aug; 216(1):169-75. PubMed ID: 8365403 [TBL] [Abstract][Full Text] [Related]
5. Platelet secretory phospholipase A2 fails to induce rabbit platelet activation and to release arachidonic acid in contrast with venom phospholipases A2. Mounier C; Vargaftig BB; Franken PA; Verheij HM; Bon C; Touqui L Biochim Biophys Acta; 1994 Aug; 1214(1):88-96. PubMed ID: 8068732 [TBL] [Abstract][Full Text] [Related]
6. Human group II 14 kDa phospholipase A2 activates human platelets. Polgár J; Kramer RM; Um SL; Jakubowski JA; Clemetson KJ Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):259-65. PubMed ID: 9355761 [TBL] [Abstract][Full Text] [Related]
7. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential). Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272 [TBL] [Abstract][Full Text] [Related]
8. Calmodulin-independent inhibition of platelet phospholipase A2 by calmodulin antagonists. Watanabe T; Hashimoto Y; Teramoto T; Kume S; Naito C; Oka H Arch Biochem Biophys; 1986 May; 246(2):699-709. PubMed ID: 3085592 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of various traditional Chinese medicines on rabbit platelet phospholipase A2 in vitro and suppressive effect of tôki-syakuyaku-san on increased aggregability in hypercholesterolemic rabbit ex vivo]. Sato T; Yamaguchi H; Fujii T; Akiba S; Tamura A; Fujii T; Tatsumi Y; Miura O Yakugaku Zasshi; 1989 Nov; 109(11):869-76. PubMed ID: 2614670 [TBL] [Abstract][Full Text] [Related]
11. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. Teng CM; Chen YH; Ouyang C Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C. Simon MF; Chap H; Douste-Blazy L Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024 [TBL] [Abstract][Full Text] [Related]
13. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action. Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791 [TBL] [Abstract][Full Text] [Related]
14. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. Mizushima H; Kudo I; Horigome K; Murakami M; Hayakawa M; Kim DK; Kondo E; Tomita M; Inoue K J Biochem; 1989 Apr; 105(4):520-5. PubMed ID: 2668261 [TBL] [Abstract][Full Text] [Related]
15. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro. Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558 [TBL] [Abstract][Full Text] [Related]
16. Possible involvement of different GTP-binding proteins in noradrenaline- and thrombin-stimulated release of arachidonic acid in rabbit platelets. Kajiyama Y; Murayama T; Kitamura Y; Imai S; Nomura Y Biochem J; 1990 Aug; 270(1):69-75. PubMed ID: 2118762 [TBL] [Abstract][Full Text] [Related]
17. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Bolliger D; Szlam F; Azran M; Koyama K; Levy JH; Molinaro RJ; Tanaka KA Anesth Analg; 2010 Sep; 111(3):601-8. PubMed ID: 20686004 [TBL] [Abstract][Full Text] [Related]
18. Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. Stasi M; Gresele P; Porcellati S; Quero E; Nenci GG; Goracci G Biochim Biophys Acta; 1992 Mar; 1124(3):279-87. PubMed ID: 1315576 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI. Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849 [TBL] [Abstract][Full Text] [Related]
20. Cellular source of human platelet secretory phospholipase A2. Emadi S; Mirshahi M; Elalamy I; Nicolas C; Vargaftig BB; Hatmi M Br J Haematol; 1998 Feb; 100(2):365-73. PubMed ID: 9488628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]